Healthcare and Life Sciences Management Consulting

July 2017

See Related Transactions

 

Sectorwatch

H1'17 exhibited consistent deal flow for the Healthcare Consulting sector.  Regardless of the outcome of an overhaul of the medical system, we continue to believe that consulting firms who help navigate the dynamic regulatory arena are in a prime position to add value to strategic acquirers.  Additionally, applying process improvement is another key area that is likely to see increased transaction activity. 

Industry Trends:

  • Current revenue growth rate is less than the average of the last 3 years, indicating that the market may be flattening or declining
  • Current gross profit margin is less than the average of the last 3 years gross profit margins, indicating customer pricing power
  • Current EBITDA margin is less than the average of the last 3 years EBITDA margins, which may signal further consolidation